135 related articles for article (PubMed ID: 35362266)
41. A 2-year retrospective study on pleural effusions: A cancer centre experience.
Valerio E; Nunes W; Cardoso J; Santos A; Bovolim G; Domingos T; De Brot L; Saieg M
Cytopathology; 2019 Nov; 30(6):607-613. PubMed ID: 31306514
[TBL] [Abstract][Full Text] [Related]
42. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
[TBL] [Abstract][Full Text] [Related]
43. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
44. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
45. Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters.
Alexandrakis MG; Kyriakou D; Alexandraki R; Pappa KA; Antonakis N; Bouros D
Respiration; 2002; 69(3):201-6. PubMed ID: 12097761
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
Sun W; Li J; Jiang HG; Ge LP; Wang Y
QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
[TBL] [Abstract][Full Text] [Related]
47. Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.
Beg S; Zanettini C; Queiroz L; Marchionni L; Alperstein SA; Siddiqui MT
J Am Soc Cytopathol; 2023; 12(6):415-422. PubMed ID: 37419704
[TBL] [Abstract][Full Text] [Related]
48. Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions.
Atalay F; Ernam D; Hasanoglu HC; Karalezli A; Kaplan O
Clin Biochem; 2005 Dec; 38(12):1066-70. PubMed ID: 16226239
[TBL] [Abstract][Full Text] [Related]
49. Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.
Liu C; Huang L; Zhang X; Yang J
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):376-381. PubMed ID: 29069463
[TBL] [Abstract][Full Text] [Related]
50. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
51. Useful tests on the pleural fluid in the management of patients with pleural effusions.
Light RW
Curr Opin Pulm Med; 1999 Jul; 5(4):245-9. PubMed ID: 10407695
[TBL] [Abstract][Full Text] [Related]
52. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
53. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
54. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
55. [Role of C-C chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
[TBL] [Abstract][Full Text] [Related]
56. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
57. Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion.
Mercer RM; Varatharajah R; Shepherd G; Lu Q; Castro-Añón O; McCracken DJ; Dudina A; Addala D; Tsikrika S; George V; Banka R; Asciak R; Hassan M; Hallifax R; Bedawi EO; Shute JK; Rahman NM
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32963027
[TBL] [Abstract][Full Text] [Related]
58. The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.
Wu H; Khosla R; Rohatgi PK; Chauhan SS; Paal E; Chen W
Lung India; 2017; 34(1):34-37. PubMed ID: 28144058
[TBL] [Abstract][Full Text] [Related]
59. The Role of Pleural Fluid C-Reactive Protein in the Diagnosis of Exudative Pleural Effusions.
Makwana S; Gohil P; Gabhawala Y
Cureus; 2022 Jul; 14(7):e27000. PubMed ID: 35874904
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]